Membrane Cholesterol but Not Putative Receptors Mediates Anandamide-Induced Hepatocyte Apoptosis

Hepatology

Volumn 38, Issue 5, 2003, Pages 1167-1177

  Biswas, Kamal Krishna ^a   Sarker, Krishna Pada ^a,b   Abeyama, Kazuhiro ^a   Kawahara, Ko Ichi ^a   Iino, Satoshi ^a   Otsubo, Yasuharu ^c   Saigo, Kazuhiko ^c   Izumi, Hiroyuki ^c   Hashiguchi, Teruto ^a   Yamakuchi, Munekazu ^a   Yamaji, Kazuyo ^a   Endo, Ryujin ^d   Suzuki, Kazuyuki ^d   Imaizumi, Hitoshi ^e   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALGARY   (Canada)

^c SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANANDAMIDE; ANTIOXIDANT; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; CHOLESTEROL; COMPACTIN; ENDOTOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN; JANUS KINASE; MEMBRANE RECEPTOR; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; POLYMYXIN; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL FATE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; FEMALE; GAP JUNCTION; HEPATITIS; HYPOTENSION; LIVER CELL; LIVER CIRRHOSIS; LIVER INJURY; MITOSIS INHIBITION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH; VASODILATATION;

EID: 0142244903     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50459     Document Type: Article

References (50)

1. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
2. Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 1999;96:12198-12203.
3. Wagner JA, Jarai Z, Batkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 2001;423:203-210.
4. Valk PJ, Delwel R. The peripheral cannabinoid receptor, Cb2, in retrovirally induced leukemic transformation and normal hematopoiesis. Leuk Lymphoma 1998;32:29-43.
5. Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, et al. Ananadamide, a natural ligand for the peripheral cannabinoid receptor, is a novel synergistic growth factor for hematopoietic cells. Blood 1997;90:1448-1457.
6. McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002;100:627-634.
7. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HHO, Das SK, Dey SK, et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 1997;100:1538-1546.
8. Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998;12:1035-1044.
9. Maccarrone M, Bari M, Menichelli A, Giuliani E, Principe DD, Finazzi-Agro A. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem 2001;268:819-825.
10. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-155.
11. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, Shimizu H, et al. Simultaneous measurement of anandamide and 2-arachidonoyl-glycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxin shock. Anal Biochem 2001;294:73-82.
12. Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001;7:827-832.
13. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study. J Cell Biol 1969;43:506-520.
14. Iwai M, Tanaka S, Mori T, Harada Y, Muramatsu A, Morikawa T, Kashima K, et al. Investigation of parenchymal cell differentiation in organotypic slice culture of mouse fetal liver under administration of sodium butyrate. Cell Biol Toxicol 2002;18:147-156.
15. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203-210.
16. 3. Biochem Biophys Res Commun 1993;192:603-609.
17. Sarker KP, Nakata M, Kitajima I, Nakajima T, Maruyama I. Inhibition of caspase-3 activation by SB 203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells. J Mol Neurosci 2000;15:243-250.
18. Kashnig DM, Kasper CB. Isolation, morphology, and composition of the nuclear membrane from rat liver. J Biol Chem 1969;244:3786-3792.
19. Colbeau A, Nachbaur J, Vignais PM. Enzymic characterization and lipid composition of rat liver subcellular membranes. Biochim Biophys Acta 1971;249:462-492.
20. Los M, Schenk H, Hexel K, Baeuerle PA, Droge W, Schulze-Osthoff K. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 1995;14:3731-3740.
21. Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett 2000;472:39-44.
22. Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hashiguchi T, Kracht M, Kitajima I, et al. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J Neuro Chem 2003;85:50-61.
23. Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T, et al. Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. Thromb Haemost 2003;89:875-884.
24. Connor J, Pak CC, Schroit AJ. Exposure of phophatidylserine in the outer leaflet of human red blood cells. Relatioship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994;269:2399-2404.
25. Namgung U, Xia Z. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J Neurosci 2000;20:6442-6451.
26. Roulston A, Reinhard C, Amiri P, Williams LT. Early activation of c-jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 1998;273:10232-10239.
27. Mackay K, Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 1999;274:6272-6279.
28. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 1996;271:31929-31936.
29. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N. The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997;11:701-713.
30. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 2000;275:31938-31945.
31. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994;350:240-244.
32. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 1998;284:644-650.
33. Hillard CJ, Jarrahian A. The movementment of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 2000;108:123-134.
34. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-afinity anandamide transport, as revealed by selective inhibition. Science 1997;277:1094-1097.
35. Mavromoustakos T, Daliani I. Effects of cannabinoids in membrane bilayers containing cholesterol. Biochim Biophys Acta 1999;1420:252-265.
36. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
37. Neufeld EB, Cooney AM, Pitha J, Dawidowicz EA, Dwyer NK, Pentchev PG, Blanchette-Mackie EJ. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J Biol Chem 1996;271:21604-21613.
38. Christian AE, Haynes MP, Phillips MC, Rothblat GH. Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 1997;38:2264-2272.
39. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and up-regulates endothelial nitric oxide synthase in mice. Stroke 2001;32:980-986.
40. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988;27:6197-6202.
41. Sankaram MB, Thompson TE. Interaction of cholesterol with various glycerophospholipids and sphingomyelin. Biochemistry 1990;29:10670-10675.
42. Scheel-Toellner D, Wang K, Singh R, Majeed S, Raza K, Curnow SJ, Salmon M, et al. The death-inducing signalling complex is recruited to lipid raft in Fas-induced apoptosis. Biochem Biophys Res Commun 2002;297:876-879.
43. Cottin V, Doan JE, Riches DW. Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain. J Immunol 2002;168:4095-4102.
44. Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997;12:223-226.
45. Kawahara H, Matsuda Y, Takase S. Is apoptosis involved in alcoholic hepatitis. Alcohol Alcohol 1994;29:113-118.
46. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, et al. Hepatic failure and liver cell damage in acute Wilsons's disease involve CD95(APO-1/Fas) mediated apoptosis. Nat Med 1998;4:588-593.
47. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995;176:373-380.
48. Sarker KP, Maruyama I. Anandamide induces cell death independently of cannabinoid receptors or vannilloid receptor 1: possible involvement of lipid rafts. Cell Mol Life Sci 2003;60:1200-1208.
49. Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Segui M, Casellas P. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett 1998;425:419-425.
50. Berdyshev EV, Schmid PC, Krebsbach RJ, Hillard CJ, Huang C, Chen N, Dong Z, et al. Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J 2001;360:67-75.